Company intelligence

MNPR

Monopar Therapeutics Inc. · NASDAQ · Healthcare

Price$110.26+0.27% · +$0.30

Market cap738.64MEquity value

P / E-50.8Trailing ratio

Volume87.76KLatest session

Market data

MNPR price chart

TradingView

Related signals

1 min delayed

Browse public MNPR signals with their source context and measured market impact. Open any signal for its permanent analysis page.

MNPROct 28, 2024-15.22% since signal

Up 600% Then Down 50% In 2 Days: What Is Going On With MNPR Stock?

MNPR stock jumped 6x due to licensing agreement for ALXN1840. ALXN1840, for Wilson Disease, could yield hundreds of millions if approved. Stock fell to $17, aligning closer with $18 analyst price estimate. MNPR has 800% gains this year, but poor performance in prior years.

View signal analysis

Research